ARBUTUS BIOPHARMA CORP's ticker is and the CUSIP is 03879J900. A total of 3 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $405,594 | -29.8% | 199,800 | -20.4% | 0.00% | -50.0% |
| Q2 2023 | $577,530 | -26.6% | 251,100 | -3.3% | 0.00% | -33.3% |
| Q1 2023 | $786,891 | +22.1% | 259,700 | -6.1% | 0.00% | +200.0% |
| Q4 2022 | $644,478 | +9.0% | 276,600 | -10.6% | 0.00% | 0.0% |
| Q3 2022 | $591,000 | -64.4% | 309,300 | -49.5% | 0.00% | -66.7% |
| Q2 2022 | $1,659,000 | +43.4% | 612,300 | +57.8% | 0.00% | +200.0% |
| Q1 2022 | $1,157,000 | -70.6% | 388,100 | -61.6% | 0.00% | -66.7% |
| Q4 2021 | $3,935,000 | +270.2% | 1,011,600 | +308.4% | 0.00% | +200.0% |
| Q3 2021 | $1,063,000 | +123.3% | 247,700 | +57.6% | 0.00% | 0.0% |
| Q2 2021 | $476,000 | -3.4% | 157,200 | +6.3% | 0.00% | 0.0% |
| Q1 2021 | $493,000 | -5.7% | 147,900 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $523,000 | +133.5% | 147,400 | +105.9% | 0.00% | 0.0% |
| Q3 2020 | $224,000 | -67.5% | 71,600 | -81.1% | 0.00% | -66.7% |
| Q2 2020 | $690,000 | +61.6% | 378,900 | -10.5% | 0.00% | 0.0% |
| Q1 2020 | $427,000 | +66.1% | 423,200 | +357.0% | 0.00% | +50.0% |
| Q4 2019 | $257,000 | +12750.0% | 92,600 | +8318.2% | 0.00% | – |
| Q2 2019 | $2,000 | -83.3% | 1,100 | -67.6% | 0.00% | – |
| Q1 2019 | $12,000 | -86.4% | 3,400 | -85.2% | 0.00% | -100.0% |
| Q4 2018 | $88,000 | -60.5% | 22,900 | -3.0% | 0.00% | -50.0% |
| Q3 2018 | $223,000 | +59.3% | 23,600 | +22.9% | 0.00% | +100.0% |
| Q2 2018 | $140,000 | +6.9% | 19,200 | -26.7% | 0.00% | 0.0% |
| Q1 2018 | $131,000 | +92.6% | 26,200 | +95.5% | 0.00% | – |
| Q4 2017 | $68,000 | +257.9% | 13,400 | +346.7% | 0.00% | – |
| Q3 2017 | $19,000 | +72.7% | 3,000 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | -56.0% | 3,000 | -70.9% | 0.00% | – |
| Q4 2016 | $25,000 | -28.6% | 10,300 | 0.0% | 0.00% | – |
| Q3 2016 | $35,000 | -27.1% | 10,300 | -25.4% | 0.00% | -100.0% |
| Q2 2016 | $48,000 | -9.4% | 13,800 | +7.8% | 0.00% | 0.0% |
| Q1 2016 | $53,000 | +60.6% | 12,800 | +73.0% | 0.00% | – |
| Q4 2015 | $33,000 | -92.2% | 7,400 | -89.4% | 0.00% | -100.0% |
| Q3 2015 | $423,000 | – | 69,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 199,800 | $405,594 | 0.00% |
| SIMPLEX TRADING, LLC | 89,500 | $181 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |